Results from meta-analysis of four GWASs in Europeans (N = 10,115), which were separately conducted in RS, TwinsUK, ALSPAC, and PITT for 78 facial shape phenotypes that are displayed in a signal …
(A) All raw landmarks before GPA process; (B) after GPA process.
(A) Sex difference (RS, N = 3,193); (B) Aging effect (RS, N = 3,193); (C) Variance explained by sex and age (RS, N = 3,193); (D) Unsupervised hierarchical clustering of phenotype correlation matrix …
Positive correlations are shown as brown squares; Negative correlations are shown as blue squares. Phenotypic correlation is shown above the diagonal and SNP-based genetic correlation is shown below …
The power of association tests under a variety of sample sizes (N = 3,000, 6,000, 10,000 and 15,000) with varied proportions of explained phenotypic variance (R2), absolute effect size (|ES|) and …
The figure is composed by six parts, (A) 1p36.22 CASZ1 region, (B) 4q28.1 INTU region, (C) 6p21.2 KIF6 region, (D) 12q24.21 TBX3 region, (E) 14q32.2 C14orf64 region, and (F) 16q12.2 RPGRIP1L region. …
(Figure 2—figure supplements 1–6 show six novel replicated loci, Figure 2—figure supplements 7–17 show 11 novel non-replicated loci, Figure 2—figure supplements 18–24 show seven previously reported …
(A) Facial phenotype variance is explained by a multivariable model consisting of 31 face-associated SNPs with independent effects. (B) Unsupervised clustering reveals the details on the explained …
Facial phenotype variance is explained by polygenic scores of 47 NSCL/P-associated SNPs after LD prune (r2 > 0.5).
Expression levels of the genes nearest to the 24 top-associated SNPs (see Table 1) in 50 cell types were displayed in boxplots based on published data from the study of Prescott et al. (2015), the …
Enrichment of the genes annotating the 24 identified face-associated genes. Enriched terms (FDR < 0.01 and n > 2, x-axis) are indicated by corrected P-value (FDR, different color), candidate genes …
Three examples of facial shape associated loci we discovered are depicted in details, including two novel loci (INTU; RPGRIP1L) and one (PAX3) that overlaps with previous face GWAS findings. The …
Discovery meta-analysis | Replication | ||||||||
---|---|---|---|---|---|---|---|---|---|
(N = 10,115) | (N = 7,917) | ||||||||
Region | SNP | Nearest Gene | EA | OA | Trait | Beta | P | Q | Com. P |
Novel face-associated loci | |||||||||
1p36.22 | rs143353512 | CASZ1 | A | G | Prn-AlL | −0.29 | 6.44 × 10−9 | 0.73 | 0.0001 |
1p36.13 | rs200243292 | ARHGEF19 | I | T | EnR-ChL | −0.11 | 1.46 × 10−8 | 0.54 | 0.0640 |
1p31.2 | rs77142479 | RPE65 | C | A | EnL-Sn | −0.08 | 7.65 × 10−9 | 0.90 | 0.0121 |
2p12 | rs10202675 | LRRTM4 | T | C | EnR-AlR | −0.26 | 4.43 × 10−8 | 0.40 | 0.0226 |
2q31.1 | rs2884836 | KIAA1715 | T | C | ExR-ChR | −0.09 | 3.04 × 10−8 | 0.52 | 0.1096 |
3q12.1 | rs113663609 | CMSS1 | A | G | EnR-ChR | −0.12 | 3.46 × 10−8 | 0.96 | 0.0782 |
4q28.1 | rs12504954 | INTU | A | G | Prn-AlL | −0.09 | 3.03 × 10−10 | 0.52 | 0.0015 |
6p22.3 | rs2225718 | RNF144B | C | T | EnR-AlR | −0.09 | 2.97 × 10−8 | 0.60 | 0.0071 |
6p21.2 | rs7738892 | KIF6 | T | C | EnR-N | 0.11 | 1.34 × 10−8 | 0.09 | 0.0018 |
8p23.2 | rs1700048 | CSMD1 | C | A | ExR-ChL | −0.22 | 3.94 × 10−8 | 0.73 | 0.1131 |
8q21.3 | rs9642796 | DCAF4L2 | A | G | AlL-Ls | −0.11 | 4.52 × 10−8 | 0.07 | 0.3090 |
10q22.1 | rs201719697 | SUPV3L1 | A | D | ExL-AlL | −0.28 | 3.42 × 10−8 | 0.66 | NA |
12q24.21 | rs1863716 | TBX3 | A | C | Prn-AlR | −0.09 | 1.47 × 10−10 | 0.53 | 2.45 × 10−5 |
13q14.3 | rs7325564 | LINC00371 | T | C | N-Prn | 0.09 | 1.34 × 10−8 | 0.16 | 0.3519 |
14q32.2 | rs1989285 | C14orf64 | G | C | N-Prn | −0.10 | 4.54 × 10−8 | 0.82 | 0.0019 |
16q12.1 | rs16949899 | SALL1 | T | G | ExR-ChL | −0.13 | 3.35 × 10−8 | 0.76 | 0.8912 |
16q12.2 | rs7404301 | RPGRIP1L | G | A | AlL-Ls | −0.09 | 3.49 × 10−9 | 0.43 | 2.87 × 10−7 |
Previously reported face-associated loci | |||||||||
1p12 | rs1229119 | TBX15 | T | C | ExR-ChR | 0.08 | 2.25 × 10−8 | 0.26 | 0.1219 |
2q36.1 | rs34032897 | PAX3 | G | A | EnR-N | 0.14 | 1.96 × 10−17 | 0.04 | 0.0020 |
4q31.3 | rs6535972 | SFRP2 | C | G | EnL-AlL | 0.12 | 3.51 × 10−12 | 0.12 | 5.89 × 10−12 |
9q22.31 | rs2230578 | ROR2 | C | T | EnL-Sn | 0.09 | 9.02 × 10−9 | 0.66 | 1.09 × 10−6 |
17q24.3 | rs8077906 | CASC17 | A | G | Prn-EnL | −0.09 | 3.00 × 10−11 | 0.24 | 0.0505 |
17q24.3 | rs35473710 | SOX9 | G | A | AlR-ChL | 0.19 | 3.95 × 10−8 | 0.37 | 0.2634 |
20p11.22 | rs4813454 | PAX1 | T | C | AlL-AlR | −0.10 | 2.32 × 10−11 | 0.58 | 0.0002 |
Except rs2230578 (3'-UTR of ROR2) and rs7738892 (a synonymous variant of KIF6), all SNPs are intronic or intergenic. Gene symbols in bold indicate successful replication after Bonferroni correction of 24 loci (p<2.1×10−3). Meta P in bold indicates study-wide significance in the discovery analysis after multiple trait correction (p<1.2×10−9). Replication P in bold means significant after Bonferroni correction for multiple tests (p<2.1×10−3). Q: p-value from the Cochran's Q test for testing heterogeneity between discovery cohorts. EA and OA, the effect allele and the another allele. Com. P: p-values from a combined test of dependent tests. NA, not available.
Supplementary Tables.
Includes: Supplementary Table 1. Characteristics of the all cohorts. Supplementary Table 2 Characteristics of 78 facial phenotypes in RS. Supplementary Table 3 Effects of 6 covariates to 78 facial phenotypes in RS. Supplementary Table 4. Phenotype correlations between all facial phenotypes in RS. Supplementary Table 5. Genetic correlation between all facial phenotypes in RS. Supplementary Table 6. Twins heritability and SNP-based heritability of all facial phenotypes in TwinsUK and QIMR. Supplementary Table7. 494 SNPs associated (p<5e-8) with facial shape phenotypes in meta-analysis of GWAS. Supplementary Table 8. Replication of reported variants of facial variation. Supplementary Table 9. GWAS Catalog entries (release on 2018-01-01), for polymorphisms that were significantly associated with facial traits in meta-analyses. Supplementary Table 10. Significant pleiotropic effect of study-wide suggestive SNPs on GeneATLAS traits. Supplementary Table 11. Frequency distribution of 24 top-associated SNPs. Supplementary Table 12. Population differentiation and positive selection at the suggestive significant GWAS SNPs. Supplementary Table 13. Replication of reported variants of NSCL/P trait. Supplementary Table 14. Multiple linear regression for 31 top-associated SNPs fitting with SEX and AGE in RS. Supplementary Table 15. Enrichment of the genes annotating the associated 24 regions. Supplementary Table 16. Significant expression quantitative trait loci effects for 494 SNPs significantly associated with facial traits and the target genes. Supplementary Table 17. Overviews of 5 selected candidate regulatory SNPs. Supplementary Table 18. Luciferase reporter assay results overview presented as relative luciferase activity fold change compared to construct containing less active allele ± standard deviation. Supplementary Table 19. Key Resource Table for functional experiments.